Sirius Therapeutics

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

France protests trigger 1,800 arrests as Macron faces nationwide crisis

Editorial infographic showing humanoid and industrial robots in a warehouse, with digital-twin mapping and key figures on commissioning, picking accuracy, operating hours and robotics orders.

Can physical AI escape the demo stage and become real industrial infrastructure?

Modal Labs has secured $750 million in Series D funding at a $15.75 billion valuation, marking a nearly 239% valuation surge in five months as demand for AI inference, GPU cloud infrastructure and autonomous coding agents accelerates, pushing the company's annualized run rate beyond $1 billion. Representative image.

Modal valuation jumps 239% as AI infrastructure demand drives $750m Series D

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Ribo enters obesity RNAi race as RBD3133 moves toward first human study in Europe

Suzhou Ribo Life Science has filed for a European Phase I trial of RBD3133, taking its first obesity candidate toward human testing as multiple RNAi developers pursue INHBE as a potential fat-selective alternative or complement to incretin therapies.

byVenkatesh

October 8, 2026

Sirius Therapeutics Initiates First-In-Human Trial of SRSD107 for Thromboembolic Disorder Treatment

Sirius Therapeutics launches SRSD107 Phase 1 trial, targeting thromboembolic disorders

Sirius Therapeutics, a pioneering biotechnology firm, has marked a significant milestone in the development of novel treatments for…

byPallavi Madhiraju

February 4, 2024

The Latest

France protests trigger 1,800 arrests as Macron faces nationwide crisis

Can physical AI escape the demo stage and become real industrial infrastructure?

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Ribo enters obesity RNAi race as RBD3133 moves toward first human study in Europe

Sirius Therapeutics launches SRSD107 Phase 1 trial, targeting thromboembolic disorders

France protests trigger 1,800 arrests as Macron faces nationwide crisis

Can physical AI escape the demo stage and become real industrial infrastructure?

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Patient volumes rose 10% at Montrose Regional Health, so why are 77 positions disappearing?

Royal Mail wants 2,500 fewer support roles. Can it afford a frontline retention problem too?

Emergent’s Q2 adjusted EBITDA hit $96.5m, so what does its CFO successor inherit?

Rath AG nearly erased its first-half loss. Why is it now closing two European factories?